Breaks Categories: News

WednesdayOct 01, 2025 9:00 am

NetworkNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Closes $7.5 Million Public Offering to Extend Cash Runway Through 2026 

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on treatments for rare diseases, announced the closing of its $7.5 million public offering of 5,555,560 shares of common stock and accompanying warrants at $1.35 per share, with proceeds intended to fund R&D, commercialization, working capital, and general corporate purposes; the financing, which included participation from existing and institutional healthcare investors, also amends prior warrants to a $1.35 exercise price and extends the company’s cash runway through the end of 2026. To view the full press release, visit https://nnw.fm/hm4Ng About Soligenix Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing…

Continue Reading

TuesdaySep 30, 2025 11:31 am

NetworkNewsBreaks – Channelchek by Noble Reports Gold Hits Record Above $3,800 Amid Dollar Weakness and Shutdown Concerns 

Channelchek, a Noble Financial Group, Inc. product and service, reports that gold surged past $3,800 an ounce to reach a record high as the U.S. dollar weakened and the prospect of a federal government shutdown fueled safe-haven demand. The rally underscores the metal’s role as a hedge against political and economic uncertainty, with investors moving into bullion amid fiscal gridlock in Washington. Analysts noted that the dollar’s decline made gold more attractive to global buyers, while escalating concerns over U.S. budget negotiations added momentum to the upward trend. To access the full report, visit https://nnw.fm/Zjbkv About Noble Capital Markets Established…

Continue Reading

TuesdaySep 30, 2025 11:14 am

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Prices $344.4 Million in PIPEs to Launch Digital Asset Treasury Strategy

Predictive Oncology (NASDAQ: POAI) announced the pricing of two concurrent private placement transactions totaling approximately $344.4 million to support its new digital asset treasury strategy centered on ATH, the native token of the Aethir ecosystem; the deal includes a $51.7 million cash PIPE and a $292.7 million crypto PIPE involving pre-funded warrants, with proceeds earmarked for ATH acquisition, working capital, and general corporate purposes. To view the full press release, visit https://nnw.fm/5LCfq About Predictive Oncology Predictive Oncology is on the cutting edge of the rapidly growing use of artificial intelligence and machine learning to expedite early drug discovery and enable…

Continue Reading

TuesdaySep 30, 2025 10:52 am

NetworkNewsBreaks – Massimo Group (NASDAQ: MAMO) Unveils 2026 MVR Series With First HVAC-Equipped Electric Carts 

Massimo Group (NASDAQ: MAMO) announced the launch of its 2026 MVR Series, introducing the MVR HVAC Golf Cart and MVR Cargo Max Electric Utility Cart—the first fully enclosed electric carts in their class to come standard with integrated heating and air conditioning, delivering up to 45 miles per charge, 25 mph top speed, and year-round comfort for recreational, municipal, and industrial users. To view the full press release, visit https://nnw.fm/HrA6o About Massimo Group Massimo Group is a manufacturer and distributor of powersports products. Headquartered in Texas, the company offers a full lineup of UTVs, ATVs, and minibikes built for outdoor adventure. Massimo…

Continue Reading

TuesdaySep 30, 2025 10:30 am

NetworkNewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Signs LOI to Acquire BioSpark AI Technologies

Fifty 1 Labs (OTC: FITY) announced it has signed a Letter of Intent to acquire BioSpark AI Technologies Inc., a Vancouver-based developer of patented AI systems for clinical data extraction and real-time analysis, in a deal that includes BioSpark’s proprietary LLM ensemble technology, intellectual property, and a contingent payment of 25 million common shares tied to revenue milestones, further advancing Fifty 1 Labs’ strategy to deliver transformative AI-powered healthcare and biotechnology solutions. To view the full press release, visit https://nnw.fm/RU9hf About Fifty1 AI Labs Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: FITY), is redefining drug discovery by…

Continue Reading

TuesdaySep 30, 2025 10:23 am

NetworkNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) CEO Highlights AI-Powered Mortgage Platform in Benzinga Podcast

Beeline Holdings (NASDAQ: BLNE) CEO Nick Liuzza was featured in a Benzinga podcast interview where he detailed the Company’s AI-driven mortgage and title services platform designed for millennials, Gen Z, and gig economy workers, noting its ability to deliver qualification decisions in under 10 minutes, support nontraditional loans, and operate debt-free with expectations to be cash-flow positive in January. To view the full press release, visit https://nnw.fm/XGSdK About Beeline Holdings, Inc. Beeline Holdings, Inc. is a trailblazing mortgage fintech transforming the way people access property financing. Through its fully digital, AI-powered platform, Beeline delivers a faster, smarter path to home…

Continue Reading

TuesdaySep 30, 2025 10:10 am

NetworkNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Highlights Exploration Potential at Bolívar Concession in Colombia

ESGold (CSE: ESAU) (OTCQB: ESAUF) outlined the prospective potential of its 1,734-hectare concession in Colombia’s Bolívar region, where historical NI 43-101 data and prior operator work identified a 3.4 km by 400-800 m structural corridor with artisanal mining, high-grade channel samples up to ~170 g/t Au, broad lower-grade drill intercepts, and untested depth potential below 200 m, consistent with a large mineralized system in one of South America’s most prolific gold-producing districts. To view the full press release, visit https://nnw.fm/OmGKU About ESGold Corp. ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) is a fully permitted, preproduction resource company at the forefront of clean mining…

Continue Reading

TuesdaySep 30, 2025 9:34 am

NetworkNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Closes Initial Tranche of $150 Million Bitcoin Investment from Scilex Holding

Datavault AI (NASDAQ: DVLT), a leader in AI-driven data visualization, valuation, and monetization, announced the closing of the initial tranche of its previously announced $150 million Bitcoin investment from Scilex Holding Company (NASDAQ: SCLX). Scilex received 15,000,000 shares of Datavault common stock at an effective purchase price of $0.5378 per share, with the balance of the investment to be issued in a second tranche through a pre-funded warrant, subject to Datavault stockholder approval for the issuance of shares exceeding 19.99% of pre-financing shares outstanding. To view the full press release, visit https://nnw.fm/bSHFs About Datavault AI Inc. Datavault AI (NASDAQ: DVLT) is…

Continue Reading

TuesdaySep 30, 2025 9:33 am

NetworkNewsBreaks – IBN Social Media Solutions Expanded by IgnitionX for Targeted Investor Engagement 

IBN (InvestorBrandNetwork) Social Media Solutions empower firms to establish branded channels, grow followership, and distribute news across Twitter, Facebook, LinkedIn and more under a consistent corporate voice. With the addition of IgnitionX, that content can be retargeted programmatically to reach investor audiences beyond the organic feed. The integration means social posts aren’t just broadcast — they can be turned into precision ads that find likely investors on Google, Meta, LinkedIn, TikTok, YouTube, Reddit and other platforms. The synergy helps clients not only build presence on social media but also amplify that presence with data-driven targeting and measurable results. While Social…

Continue Reading

TuesdaySep 30, 2025 9:20 am

NetworkNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Expands European Medical Advisory Board to Advance HyBryte Phase 3 Study 

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on treatments for rare diseases, announced the expansion of its European Medical Advisory Board to guide its confirmatory Phase 3 trial of HyBryte(TM) in early-stage cutaneous T-cell lymphoma, an 18-week study enrolling about 80 patients with top-line results expected in the second half of 2026, as the company strengthens European engagement ahead of potential commercialization. To view the full press release, visit https://nnw.fm/ivOYn About Soligenix Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our Specialized BioTherapeutics business…

Continue Reading